Two in one: Multi-tasking protein provides new approaches for anti-tuberculosis drugs
Tuesday, February 15, 2011 - 09:30
in Health & Medicine
Scientists have revealed new insights into the workings of an enzyme from Mycobacterium tuberculosis, the bacterium that causes tuberculosis. The findings present new opportunities for developing organism-specific drugs, which target the pathogen but leave other microorganisms, which are beneficial to us, untouched.